You want to be a CBO? Four tips to set you on your way

Most of the titles in a biotech C-suite are generally self-explanatory. The Chief Technical and Manufacturing Officer runs operations in CMC and analytics. The Chief Financial Officer handles financial strategy and investor relations. The Chief Commercial Officer prepares for bringing investigational therapies to market. Then there’s the title I hold: Chief Business Officer (CBO). This […]

Treating the whole body: The case for lentiviral gene therapy’s head-to-toe reach

We hear it regularly from patients and caregivers: There’s an urgent need for therapies that can treat the whole body to address the full range of symptoms in diseases that manifest in both the central nervous system (CNS) and peripheral tissues. Biologically, that’s a tall order. The brain is protected by an intricate blood-brain barrier […]

Our second wave: How tag technology is driving exciting preclinical results in Pompe disease research

At AVROBIO, we’ve been highly strategic in selecting our second wave of programs for our leading lentiviral gene therapy pipeline. We’re targeting three devastating lysosomal disorders in this next wave – Pompe disease, Hunter syndrome and Gaucher disease type 3 – each of which impacts multiple organ systems throughout the body and is marked by […]

You can’t yoga your way out of burnout: Reflections on keeping a team energized and productive during a pandemic

This pandemic year has been tough on all of us. But as I reflect back on 2020, I’ve realized that the strains also brought opportunity. The profound dislocations of the year prompted new ways of thinking about nurturing team culture, buoying morale and maintaining strong forward momentum as a business amid steep challenges. As chief […]